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Introduction:  
Gastrointestinal (GI) malignancy is a common finding in iron deficiency anaemia (IDA), with a 
prevalence of about 8%. We have previously reported and validated an algorithm for predicting 
the risk of GI malignancy in IDA – the IDIOM score. This was derived by logistic regression 
analysis based on four independent and objective clinical parameters - age, sex, mean 
corpuscular volume (MCV), and haemoglobin concentration (Hb). To facilitate the clinical use 
of this algorithm, a software application has been developed, with a view to providing free and 
simple access to healthcare professionals in the UK. 
Methods: 
A detailed requirements analysis for intended users of the application revealed the need for 
an automated tool in which anonymised, individual, patient data is entered and GI cancer risk 
is calculated and displayed. The solution needed to be user-friendly and platform independent, 
and needed to facilitate future communication with the development team. Human-centred 
design (HCD) was employed to develop the solution, focusing on the users and their needs, 
whilst ensuring that they are provided with sufficient details to appropriately interpret the risk 
score. To evaluate usability, standard usability questionnaire applied. Participants include 
healthcare professionals such as IDA nurse specialists, gastroenterologists, etc. 
Results:  
Predict GI Cancer in IDA has been developed using R Shiny as a web-based application 
enabling access from different platforms with central updating. The application has been 
evaluated and tested through literature search, internal validation exercises, code testing, risk 
analysis, and usability assessments. Usability assessments (n=7) has shown mean user 
subjective satisfaction of 8.5 out of 10.  A screenshot from the application is shown in Figure 
1. Plans for post-production maintenance and surveillance have been established. A technical 
file for the application has been written according to Medical Devices Directive (MDD) and all 
other relevant harmonised standards. The process of registering the application with the 
MHRA and for CE marking is underway.  
Conclusions:  
The application Predict GI Cancer in IDA generates an estimate of GI cancer risk (with 95% 
confidence interval), following the insertion of data for the four key variables. The whole 
process takes just a few seconds, which lends itself to use in busy clinical settings. Legal 
notices, contact system and all the supportive information for the application such as 
description of the population, intended users, safety information have been embedded within 
the application interface.  
